Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1946257
Max Phase: Preclinical
Molecular Formula: C23H26ClN3OS
Molecular Weight: 428.00
Molecule Type: Small molecule
Associated Items:
ID: ALA1946257
Max Phase: Preclinical
Molecular Formula: C23H26ClN3OS
Molecular Weight: 428.00
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(CCCCN1CCCN(c2ccc(Cl)cc2)CC1)c1nc2ccccc2s1
Standard InChI: InChI=1S/C23H26ClN3OS/c24-18-9-11-19(12-10-18)27-15-5-14-26(16-17-27)13-4-3-7-21(28)23-25-20-6-1-2-8-22(20)29-23/h1-2,6,8-12H,3-5,7,13-17H2
Standard InChI Key: QLTASWSCCMMISJ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 428.00 | Molecular Weight (Monoisotopic): 427.1485 | AlogP: 5.52 | #Rotatable Bonds: 7 |
Polar Surface Area: 36.44 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 4 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 8.46 | CX LogP: 5.31 | CX LogD: 4.22 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.37 | Np Likeness Score: -1.88 |
1. Peprah K, Zhu XY, Eyunni SV, Etukala JR, Setola V, Roth BL, Ablordeppey SY.. (2012) Structure-activity relationship studies of SYA 013, a homopiperazine analog of haloperidol., 20 (5): [PMID:22336245] [10.1016/j.bmc.2012.01.022] |
2. Zhu XY, Etukala JR, Eyunni SV, Setola V, Roth BL, Ablordeppey SY.. (2012) Benzothiazoles as probes for the 5HT1A receptor and the serotonin transporter (SERT): a search for new dual-acting agents as potential antidepressants., 53 [PMID:22520153] [10.1016/j.ejmech.2012.03.042] |
Source(1):